Lung neoplasm
Conditions
Interventions
1:Deep serratus anterior group: under the guidance of ultrasound, the fourth intercostal needle was inserted in the midaxillary line of the affected side, and 20ml of 0.5% ropivacaine was injected int
2:Superficial serratus anterior group: under the guidance of ultrasound, the fourth intercostal needle was inserted in the midaxillary line on the affected side, and 20ml ropivacaine (0.5%) was inject
3:In the complex group of superficial and deep serratus anterior muscle, 7ml ropivacaine 0.5% was injected into the deep surface of serratus anterior muscle and 13ml ropivacaine 0.5% was injected into
4:Paravertebral group: 20ml of 0.5% ropivacaine was injected into the median line 1.5-2.0cm T5 after the intercostal space of the affected side under ultrasound guidance, followed by general anesthesi
Sponsors
The First Hospital of China Medical University
Eligibility
Sex/Gender
All
Age
16 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Aged 16-80 years; 2. Selective lobectomy; 3. ASA class I- III.
Exclusion criteria
Exclusion criteria: 1. Patients with contraindication of nerve block, such as infection of puncture site, spinal deformity, trauma or operation history; 2. Allergic to local anesthetics or opioids; 3. Patients with severe motion sickness; 4. Dyslexic.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| VAS;Opioid dosage;Opioid side effects;Hemodynamic change;Pain relief satisfaction;Dosage of vasoactive drugs; | — |
Secondary
| Measure | Time frame |
|---|---|
| Lung function; | — |
Countries
China
Contacts
Public ContactCao Xuezhao
Anaesthesia Department, The First Hospital of China Medical University
Outcome results
None listed